Roles of the WHHL Rabbit in Translational Research on Hypercholesterolemia and Cardiovascular Diseases
Authors:
Open Access
- 1 January 2011
- journal article
- review article
- Published by Wiley in BioMed Research International
- Vol. 2011 (1) , 406473
Abstract
Conquering cardiovascular diseases is one of the most important problems in human health. To overcome cardiovascular diseases, animal models have played important roles. Although the prevalence of genetically modified animals, particularly mice and rats, has contributed greatly to biomedical research, not all human diseases can be investigated in this way. In the study of cardiovascular diseases, mice and rats are inappropriate because of marked differences in lipoprotein metabolism, pathophysiological findings of atherosclerosis, and cardiac function. On the other hand, since lipoprotein metabolism and atherosclerotic lesions in rabbits closely resemble those in humans, several useful animal models for these diseases have been developed in rabbits. One of the most famous of these is the Watanabe heritable hyperlipidemic (WHHL) rabbit, which develops hypercholesterolemia and atherosclerosis spontaneously due to genetic and functional deficiencies of the low‐density lipoprotein (LDL) receptor. The WHHL rabbit has been improved to develop myocardial infarction, and the new strain was designated the myocardial infarction‐prone WHHL (WHHLMI) rabbit. This review summarizes the importance of selecting animal species for translational research in biomedical science, the development of WHHL and WHHLMI rabbits, their application to the development of hypocholesterolemic and/or antiatherosclerotic drugs, and future prospects regarding WHHL and WHHLMI rabbits.Keywords
This publication has 80 references indexed in Scilit:
- Renin Inhibitor Aliskiren Improves Impaired Nitric Oxide Bioavailability and Protects Against Atherosclerotic ChangesHypertension, 2008
- Lapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipid‐rich coronary plaques of hypercholesterolaemic rabbits into fibrous lesionsBritish Journal of Pharmacology, 2008
- Relation Between Plasma Adiponectin, High-Sensitivity C-Reactive Protein, and Coronary Plaque Components in Patients With Acute Coronary SyndromeThe American Journal of Cardiology, 2008
- Phenotype Interaction of apobec-1 and CETP , LDLR, and ApoE Gene Expression in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Reduction of Serum Cholesterol Levels Alters Lesional Composition of Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1992
- Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Cholestyramine treatment in early life of low-density lipoprotein receptor deficient Watanabe rabbits: decreased aortic cholesteryl ester accumulation and atherosclerosis in adult lifeBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- WHHL‐Rabbit: a low density lipoprotein receptor‐deficient animal model for familial hypercholesterolemiaFEBS Letters, 1980